- Investing Ideas
- U.S. Healthcare Undervalued based on future growth
U.S. Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
CONMED
Market Cap: US$1.3b
A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
CNMD
US$42.68
7D
-1.2%
1Y
-16.2%
GMR Solutions
Market Cap: US$1.0b
Operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States.
GMRS
US$12.97
7D
-2.8%
1Y
n/a
Nutex Health
Market Cap: US$1.0b
Operates as a healthcare services and operations company in the United States.
NUTX
US$145.87
7D
-10.5%
1Y
53.5%
Auna
Market Cap: US$373.0m
A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA
US$5.04
7D
-1.6%
1Y
-19.6%
OptimizeRx
Market Cap: US$117.1m
Operates as a digital healthcare technology company.
OPRX
US$6.24
7D
-6.7%
1Y
-56.5%
CareCloud
Market Cap: US$94.3m
A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$2.22
7D
-4.3%
1Y
-9.4%
Xtant Medical Holdings
Market Cap: US$60.1m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.43
7D
-4.7%
1Y
-30.9%